nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinitapride—HTR2A—arteriole—atherosclerosis	0.0789	0.299	CbGeAlD
Cinitapride—HTR2A—vein—atherosclerosis	0.047	0.178	CbGeAlD
Cinitapride—HTR2A—hindlimb—atherosclerosis	0.0313	0.118	CbGeAlD
Cinitapride—HTR2A—appendage—atherosclerosis	0.0268	0.102	CbGeAlD
Cinitapride—HTR2A—artery—atherosclerosis	0.0192	0.0726	CbGeAlD
Cinitapride—HTR2A—endothelium—atherosclerosis	0.0162	0.0613	CbGeAlD
Cinitapride—HTR2A—blood vessel—atherosclerosis	0.0149	0.0566	CbGeAlD
Cinitapride—HTR1A—cardiovascular system—atherosclerosis	0.0112	0.0423	CbGeAlD
Cinitapride—HTR2A—connective tissue—atherosclerosis	0.00765	0.029	CbGeAlD
Cinitapride—HTR2A—cardiovascular system—atherosclerosis	0.00666	0.0252	CbGeAlD
Cinitapride—HTR2A—liver—atherosclerosis	0.00412	0.0156	CbGeAlD
Cinitapride—HTR4—Signaling Pathways—IGF2—atherosclerosis	0.000742	0.00101	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCL4—atherosclerosis	0.000741	0.00101	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CCL5—atherosclerosis	0.000739	0.001	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CX3CR1—atherosclerosis	0.000733	0.000996	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CASR—atherosclerosis	0.000733	0.000996	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—UTS2—atherosclerosis	0.000727	0.000988	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—APOB—atherosclerosis	0.00072	0.000979	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CX3CL1—atherosclerosis	0.000719	0.000976	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—CXCL8—atherosclerosis	0.000714	0.00097	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000713	0.000968	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—EDN1—atherosclerosis	0.000709	0.000963	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CCL5—atherosclerosis	0.000704	0.000956	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.000701	0.000952	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HRH1—atherosclerosis	0.000701	0.000952	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CASR—atherosclerosis	0.000697	0.000947	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—LPL—atherosclerosis	0.000688	0.000935	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CNR2—atherosclerosis	0.000681	0.000926	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PRKCG—atherosclerosis	0.000669	0.000909	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000668	0.000908	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—CXCL8—atherosclerosis	0.000664	0.000903	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—UTS2—atherosclerosis	0.00066	0.000897	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—SPP1—atherosclerosis	0.000652	0.000885	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—CXCL8—atherosclerosis	0.000649	0.000881	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CNR2—atherosclerosis	0.000648	0.000881	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000648	0.00088	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000647	0.000879	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—EDN1—atherosclerosis	0.000643	0.000874	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000642	0.000872	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CCL5—atherosclerosis	0.000638	0.000867	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CX3CR1—atherosclerosis	0.000633	0.00086	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CASR—atherosclerosis	0.000633	0.00086	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CX3CL1—atherosclerosis	0.000621	0.000844	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—AGT—atherosclerosis	0.000618	0.000839	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HRH1—atherosclerosis	0.000605	0.000823	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PDGFB—atherosclerosis	0.000603	0.000819	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CNR2—atherosclerosis	0.000589	0.0008	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—AGT—atherosclerosis	0.000589	0.000799	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CCL3—atherosclerosis	0.000586	0.000796	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—EDNRA—atherosclerosis	0.000584	0.000793	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CCR2—atherosclerosis	0.000584	0.000793	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000577	0.000784	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—APOE—atherosclerosis	0.000577	0.000783	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—LEP—atherosclerosis	0.000577	0.000783	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CAV1—atherosclerosis	0.000571	0.000776	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—F2—atherosclerosis	0.000571	0.000776	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—APOA1—atherosclerosis	0.00057	0.000774	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—GHRL—atherosclerosis	0.000569	0.000773	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000555	0.000753	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—ESR1—atherosclerosis	0.000551	0.000748	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APOA4—atherosclerosis	0.00055	0.000747	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—F2—atherosclerosis	0.000544	0.000739	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—AGT—atherosclerosis	0.000534	0.000725	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—EDNRA—atherosclerosis	0.00053	0.00072	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CCR2—atherosclerosis	0.00053	0.00072	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000528	0.000718	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PIK3CG—atherosclerosis	0.00052	0.000707	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000518	0.000704	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—GHRL—atherosclerosis	0.000516	0.000702	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CCL2—atherosclerosis	0.000509	0.000691	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCL4—atherosclerosis	0.000507	0.000688	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCL3—atherosclerosis	0.000506	0.000688	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—EDNRA—atherosclerosis	0.000504	0.000685	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CCR2—atherosclerosis	0.000504	0.000685	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—KNG1—atherosclerosis	0.000499	0.000678	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—MAPK3—atherosclerosis	0.000498	0.000677	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AGTR1—atherosclerosis	0.000496	0.000674	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—F2—atherosclerosis	0.000493	0.00067	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—INS—atherosclerosis	0.000493	0.000669	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—GHRL—atherosclerosis	0.000491	0.000667	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CCL2—atherosclerosis	0.000485	0.000658	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IGF1—atherosclerosis	0.000476	0.000647	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APOA4—atherosclerosis	0.000475	0.000645	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000474	0.000643	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APOA2—atherosclerosis	0.000473	0.000643	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—EDNRA—atherosclerosis	0.000458	0.000622	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCR2—atherosclerosis	0.000458	0.000622	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000456	0.00062	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—KNG1—atherosclerosis	0.000453	0.000616	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—SERPINE1—atherosclerosis	0.000452	0.000615	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—UTS2—atherosclerosis	0.000452	0.000614	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AGTR1—atherosclerosis	0.000451	0.000612	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000448	0.000608	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—GHRL—atherosclerosis	0.000446	0.000606	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CCL2—atherosclerosis	0.00044	0.000597	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCL4—atherosclerosis	0.000438	0.000595	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CX3CR1—atherosclerosis	0.000433	0.000588	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CASR—atherosclerosis	0.000433	0.000588	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NOS3—atherosclerosis	0.000432	0.000587	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—KNG1—atherosclerosis	0.000431	0.000586	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AGTR1—atherosclerosis	0.000429	0.000582	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CX3CL1—atherosclerosis	0.000425	0.000577	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—EDN1—atherosclerosis	0.000421	0.000571	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CCL5—atherosclerosis	0.000417	0.000567	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APOA2—atherosclerosis	0.000409	0.000556	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CNR2—atherosclerosis	0.000403	0.000547	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CXCL8—atherosclerosis	0.000402	0.000547	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—MMP3—atherosclerosis	0.000402	0.000546	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PRKCG—atherosclerosis	0.000397	0.000539	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—KNG1—atherosclerosis	0.000392	0.000532	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—UTS2—atherosclerosis	0.00039	0.00053	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AGTR1—atherosclerosis	0.000389	0.000529	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CXCL8—atherosclerosis	0.000383	0.000521	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—EDN1—atherosclerosis	0.000382	0.000519	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CCL5—atherosclerosis	0.000379	0.000515	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CX3CR1—atherosclerosis	0.000374	0.000508	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CASR—atherosclerosis	0.000374	0.000508	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—AKT1—atherosclerosis	0.00037	0.000503	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CX3CL1—atherosclerosis	0.000367	0.000498	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—IL6—atherosclerosis	0.000364	0.000495	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—EDN1—atherosclerosis	0.000363	0.000494	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CCL5—atherosclerosis	0.000361	0.00049	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PRKCG—atherosclerosis	0.00036	0.00049	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—VWF—atherosclerosis	0.000359	0.000487	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APOC3—atherosclerosis	0.000357	0.000484	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—LDLR—atherosclerosis	0.000354	0.000481	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AGT—atherosclerosis	0.000349	0.000474	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CNR2—atherosclerosis	0.000348	0.000472	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CXCL8—atherosclerosis	0.000348	0.000472	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—MMP3—atherosclerosis	0.000347	0.000471	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MMP9—atherosclerosis	0.000347	0.000471	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000346	0.00047	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCL3—atherosclerosis	0.000346	0.00047	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NFKB1—atherosclerosis	0.000343	0.000466	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PRKCG—atherosclerosis	0.000343	0.000466	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MAPK8—atherosclerosis	0.000337	0.000458	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—AKT1—atherosclerosis	0.000336	0.000457	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NCF1—atherosclerosis	0.000331	0.00045	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—EDN1—atherosclerosis	0.00033	0.000448	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCL5—atherosclerosis	0.000327	0.000445	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—F2—atherosclerosis	0.000323	0.000438	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AGT—atherosclerosis	0.000317	0.000431	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCR2—atherosclerosis	0.000313	0.000425	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EDNRA—atherosclerosis	0.000313	0.000425	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CYBA—atherosclerosis	0.000312	0.000423	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PRKCG—atherosclerosis	0.000311	0.000423	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—VEGFA—atherosclerosis	0.000311	0.000423	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—VWF—atherosclerosis	0.00031	0.000421	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000309	0.000419	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—STAT3—atherosclerosis	0.000308	0.000419	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APOC3—atherosclerosis	0.000308	0.000418	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LDLR—atherosclerosis	0.000306	0.000416	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GHRL—atherosclerosis	0.000305	0.000414	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PARP1—atherosclerosis	0.000305	0.000414	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PLAT—atherosclerosis	0.000305	0.000414	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AGT—atherosclerosis	0.000302	0.00041	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCL3—atherosclerosis	0.000299	0.000406	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MAPK3—atherosclerosis	0.000294	0.0004	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—F2—atherosclerosis	0.000293	0.000398	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NCF1—atherosclerosis	0.000286	0.000389	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TGFB1—atherosclerosis	0.000286	0.000388	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3CG—atherosclerosis	0.00028	0.000381	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—F2—atherosclerosis	0.000279	0.000379	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AGT—atherosclerosis	0.000274	0.000372	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCR2—atherosclerosis	0.00027	0.000367	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EDNRA—atherosclerosis	0.00027	0.000367	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CYBA—atherosclerosis	0.000269	0.000366	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—KNG1—atherosclerosis	0.000268	0.000364	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000267	0.000362	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AGTR1—atherosclerosis	0.000266	0.000362	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PLAT—atherosclerosis	0.000264	0.000358	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GHRL—atherosclerosis	0.000264	0.000358	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PARP1—atherosclerosis	0.000264	0.000358	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CCL2—atherosclerosis	0.000261	0.000355	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PLG—atherosclerosis	0.000259	0.000352	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—F2—atherosclerosis	0.000253	0.000344	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SOCS3—atherosclerosis	0.000246	0.000334	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000242	0.000329	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MMP3—atherosclerosis	0.000237	0.000322	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IGF2—atherosclerosis	0.000236	0.000321	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—KNG1—atherosclerosis	0.000231	0.000314	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AGTR1—atherosclerosis	0.00023	0.000312	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APOB—atherosclerosis	0.000229	0.000311	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000227	0.000309	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EDN1—atherosclerosis	0.000226	0.000307	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCL2—atherosclerosis	0.000226	0.000306	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PLG—atherosclerosis	0.000224	0.000304	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCL5—atherosclerosis	0.000224	0.000304	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—LPL—atherosclerosis	0.000219	0.000297	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IL6—atherosclerosis	0.000215	0.000292	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PRKCG—atherosclerosis	0.000213	0.000289	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SOCS3—atherosclerosis	0.000212	0.000288	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SPP1—atherosclerosis	0.000207	0.000282	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CXCL8—atherosclerosis	0.000206	0.00028	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MMP3—atherosclerosis	0.000205	0.000278	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IGF2—atherosclerosis	0.000204	0.000277	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—AKT1—atherosclerosis	0.000199	0.00027	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APOB—atherosclerosis	0.000198	0.000269	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000196	0.000267	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EDN1—atherosclerosis	0.000195	0.000265	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCL5—atherosclerosis	0.000193	0.000263	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PDGFB—atherosclerosis	0.000192	0.000261	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LPL—atherosclerosis	0.000189	0.000257	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AGT—atherosclerosis	0.000187	0.000254	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PRKCG—atherosclerosis	0.000184	0.00025	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APOE—atherosclerosis	0.000184	0.000249	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—LEP—atherosclerosis	0.000184	0.000249	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CAV1—atherosclerosis	0.000182	0.000247	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APOA1—atherosclerosis	0.000181	0.000246	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SPP1—atherosclerosis	0.000179	0.000243	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CXCL8—atherosclerosis	0.000178	0.000242	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ESR1—atherosclerosis	0.000175	0.000238	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—F2—atherosclerosis	0.000173	0.000235	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PDGFB—atherosclerosis	0.000166	0.000225	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3CG—atherosclerosis	0.000166	0.000225	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AGT—atherosclerosis	0.000162	0.00022	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—MAPK3—atherosclerosis	0.000159	0.000215	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APOE—atherosclerosis	0.000159	0.000215	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LEP—atherosclerosis	0.000159	0.000215	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CAV1—atherosclerosis	0.000157	0.000213	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—INS—atherosclerosis	0.000157	0.000213	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APOA1—atherosclerosis	0.000157	0.000213	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCL2—atherosclerosis	0.000154	0.00021	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IGF1—atherosclerosis	0.000152	0.000206	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ESR1—atherosclerosis	0.000151	0.000206	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—F2—atherosclerosis	0.00015	0.000203	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SERPINE1—atherosclerosis	0.000144	0.000196	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3CG—atherosclerosis	0.000143	0.000194	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NOS3—atherosclerosis	0.000137	0.000187	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—MAPK3—atherosclerosis	0.000137	0.000186	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—INS—atherosclerosis	0.000135	0.000184	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCL2—atherosclerosis	0.000133	0.000181	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IGF1—atherosclerosis	0.000131	0.000178	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SERPINE1—atherosclerosis	0.000124	0.000169	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	0.000122	0.000166	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NOS3—atherosclerosis	0.000119	0.000161	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	0.000118	0.00016	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL6—atherosclerosis	0.000116	0.000158	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MMP9—atherosclerosis	0.00011	0.00015	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	0.000109	0.000148	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	0.000107	0.000146	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	0.000107	0.000145	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	0.000105	0.000143	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	0.000102	0.000138	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL6—atherosclerosis	0.0001	0.000136	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	9.91e-05	0.000135	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—STAT3—atherosclerosis	9.81e-05	0.000133	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MMP9—atherosclerosis	9.53e-05	0.000129	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	9.43e-05	0.000128	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	9.37e-05	0.000127	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	9.27e-05	0.000126	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	9.24e-05	0.000126	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	9.09e-05	0.000124	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	8.56e-05	0.000116	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—STAT3—atherosclerosis	8.47e-05	0.000115	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	8.09e-05	0.00011	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	7.85e-05	0.000107	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL6—atherosclerosis	6.85e-05	9.31e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKT1—atherosclerosis	6.32e-05	8.59e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL6—atherosclerosis	5.92e-05	8.04e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKT1—atherosclerosis	5.46e-05	7.42e-05	CbGpPWpGaD
